Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Moleculin Biotech, Inc.

Clinical trials sponsored by Moleculin Biotech, Inc., explained in plain language.

Moleculin Biotech, Inc. MBRX NASDAQ

A clinical-stage biopharmaceutical company developing treatments for hard-to-treat cancers.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 1

New hope for AML patients: experimental drug combo tested

Disease control Completed

This study tested a new drug called liposomal annamycin combined with standard chemotherapy (cytarabine) in 22 adults with acute myeloid leukemia (AML). The goal was to find the safest dose and see if the combination can control the disease. Participants had either newly diagnose…

Phase: PHASE1, PHASE2 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC